HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Prognostic factors of pneumococcal meningitis. Retrospective study of 31 cases].

AbstractAIM:
Our aim was to study the susceptibility of Streptococcus pneumoniae to antibiotics in patients with pneumococcal meningitis and to search for the prognosis factors in those patients.
METHODS:
We have studied retrospectively 31 cases of pneumococcal meningitis. Comparaisons were performed with univariate analysis.
RESULTS:
The mean age was 36.7 +/- 20.5 years (ranged: 9 and 78 years). The sex ratio was 3,4. The susceptibility of Streptococcus pneumoniae to penicillin G was affected in 10 cases (33% of isolated pneumococcus. The MIC to penicillin G was > or =2 in only one case. The hospital mortality was 26% (8/31). With univariate analysis, factors associated with death were: age > or =55 years (Ss p= 0,006, OR: 17.2 IC95%: 2.3-134), albuminorachie > or = 7 g/l (p = 0.002, OR: 22; IC95%: 1.9-2.51), shock (p = 0.031, OR: 6.7; IC95%: 1.05-42) and Glasgow Coma Score (GCS) < or =8 (p = 0.001, OR: 20; IC95%: 2.68-149).
CONCLUSION:
No susceptibility to penicillin G is not associated with a worse outcome in patients with pneumococcal meningitis. An age > or =55 years, albuminorachie > or =7 g/l shock and Glasgow Coma Score < or =8 at admission were determinant of the prognosis in our study.
AuthorsH Kallel, I Mâaloul, F Mahjoubi, H Dammak, H Ghorbel, H Chelly, H Ksibi, C Ben Hamida, N Rekik, M Ben Jemaa, A Hammami, M Bouaziz
JournalLa Tunisie medicale (Tunis Med) Vol. 85 Issue 8 Pg. 692-6 (Aug 2007) ISSN: 0041-4131 [Print] Tunisia
Vernacular TitleFacteurs de pronostic des méningites à pneumocoque. Etude rétrospective de 31 cas.
PMID18254294 (Publication Type: English Abstract, Journal Article)
Topics
  • Adolescent
  • Adult
  • Aged
  • Child
  • Female
  • Humans
  • Male
  • Meningitis, Pneumococcal (drug therapy)
  • Middle Aged
  • Prognosis
  • Retrospective Studies
  • Streptococcus pneumoniae (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: